LAS VEGAS, Nov. 9, 2015 /PRNewswire/ -- DigiPath Labs, a subsidiary of DigiPath, Inc. (OTCQB: DIGP), has recently made a deal with Las Vegas Herbal Growers to perform all of their safety and potency testing on its cannabis.
"We look forward to working with Las Vegas Herbal Growers," says DigiPath CEO Todd Denkin. "Our goal is to deliver excellent customer service, including free pickup and 48 hour turnaround, so they can focus on growing medicinal cannabis that will benefit patients and meet the strict safety standards required by the State of Nevada."
DigiPath Labs' flagship Las Vegas location is a state-of-the-art cannabis testing lab that combines top-of-the-line equipment and exacting standard operating procedures to ensure that its test results are accurate and fast. DigiPath Labs will test plant material from Las Vegas Herbal Growers for moisture content, potency, terpenoids, foreign matter, microbials, mycotoxins, heavy metals, and pesticide residue.
"We knew we'd found the right testing lab when we met with DigiPath Labs," explains a Las Vegas Herbal Growers owner. "Like us, they truly care about patient safety, and the care they put into setting up and operating the lab proves it. We look forward to working with DigiPath Labs for many years to come."
To learn more about DigiPath Labs, visit www.digipathlabs.com.
About DigiPath, Inc.
DigiPath, Inc., supports the cannabis industry's best practices for reliable testing, education, and training, and brings unbiased cannabis news coverage to the nation. DigiPath's two business units are DigiPath Labs and TNM News Corp.
For more information, go to www.digipath.com.
Information about Forward-Looking Statements
This press release contains "forward-looking statements" that include information relating to future events, and future financial and operating performance. Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management's good faith belief as of that time with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in, or suggested by, the forward-looking statements. Important factors that could cause these differences include, but are not limited to: the demand for the Company's products, governmental regulation of the cannabis industry, the introduction of new products, the Company's ability to maintain customer and strategic business relationships, the impact of competitive products and pricing, growth in targeted markets, the adequacy of the Company's liquidity and financial strength to support its growth, and other information that may be detailed from time-to-time in the Company's filings with the United States Securities and Exchange Commission. For a more detailed description of the risk factors and uncertainties affecting DigiPath, please refer to the Company's recent Securities and Exchange Commission filings, which are available at www.sec.gov. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.
Media Contact: DigiPath Labs, Inc.
SOURCE DigiPath, Inc.